Literature DB >> 25851111

Overlap between linear scleroderma, progressive facial hemiatrophy and immune-inflammatory encephalitis in a paediatric cohort.

Lien De Somer1, Marie-Anne Morren, P C E Hissink Muller, Karine Despontin, Katrien Jansen, Lieven Lagae, Carine Wouters.   

Abstract

Linear scleroderma en coup the sabre (LSCS), progressive facial hemiatrophy (PFH) and autoimmune encephalitis are distinct clinical entities, although patients with overlapping features have been reported. We performed a multicenter retrospective review of a series of children with LSCS and/or PFH to explore the relation between these entities. The files of 16 children were reviewed, 11 presented with LSCS, 5 with PFH, with time overlapping cutaneous features were seen. Extracutaneous signs were found in both groups. ANA were present in more than 50 % of patients. Almost half of our patients presented with CNS manifestations comprising unilateral headache, migraine and epilepsy with or without abnormalities on MRI. Brain biopsy in one patient was consistent with Rasmussen encephalitis. In two other children, associated autoimmune manifestations were present.
CONCLUSION: Our patient cohort brings more arguments to consider LSCS and PFH as a single disease entity with LSCS and superficial skin involvement at one end of the spectrum and PFH with involvement of subcutaneous deep tissue at the other end. In both entities, encephalitis can be observed. Our findings of circulating ANA, intradermal lymphocytes and IgG, intrathecal IgG production and clinical improvement with immunosuppressive therapy endorse the concept of a possible common immune-inflammatory pathogenesis. WHAT IS KNOWN: • LSCS, PFH and immune-inflammatory encephalitis are distinct clinical entities, but patients with overlapping features have been reported. WHAT IS NEW: • We present a unique paediatric cohort with LSCS, PFH and/or encephalitis. • We endorse the concept of a common immune-inflammatory disease process.

Entities:  

Mesh:

Year:  2015        PMID: 25851111     DOI: 10.1007/s00431-015-2532-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

Review 1.  A review of Parry-Romberg syndrome.

Authors:  Jessica El-Kehdy; Ossama Abbas; Nelly Rubeiz
Journal:  J Am Acad Dermatol       Date:  2012-03-07       Impact factor: 11.527

2.  En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.

Authors:  Megha M Tollefson; Patricia M Witman
Journal:  J Am Acad Dermatol       Date:  2006-12-04       Impact factor: 11.527

3.  Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology.

Authors:  C G Bien; H Urbach; M Deckert; J Schramm; O D Wiestler; H Lassmann; C E Elger
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

4.  Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.

Authors:  F Zulian; B H Athreya; R Laxer; A M Nelson; S K Feitosa de Oliveira; M G Punaro; R Cuttica; G C Higgins; L W A Van Suijlekom-Smit; T L Moore; C Lindsley; J Garcia-Consuegra; M O Esteves Hilário; L Lepore; C A Silva; C Machado; S M Garay; Y Uziel; G Martini; I Foeldvari; A Peserico; P Woo; J Harper
Journal:  Rheumatology (Oxford)       Date:  2005-12-20       Impact factor: 7.580

5.  Correlation between magnetic resonance imaging and histopathologic grades in Rasmussen syndrome.

Authors:  Sun Jun Kim; Yong D Park; Richard Hessler; Mark R Lee; Joseph R Smith
Journal:  Pediatr Neurol       Date:  2010-03       Impact factor: 3.372

Review 6.  Autoimmune encephalitis in children.

Authors:  Thaís Armangue; Mar Petit-Pedrol; Josep Dalmau
Journal:  J Child Neurol       Date:  2012-08-29       Impact factor: 1.987

7.  Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome.

Authors:  Justyna Paprocka; Ewa Jamroz; Dariusz Adamek; Elzbieta Marszal; Marek Mandera
Journal:  Childs Nerv Syst       Date:  2005-10-25       Impact factor: 1.475

Review 8.  Cytokine profiles in localized scleroderma and relationship to clinical features.

Authors:  Katherine Kurzinski; Kathryn S Torok
Journal:  Cytokine       Date:  2011-05-04       Impact factor: 3.861

9.  Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.

Authors:  Francesco Zulian; Giorgia Martini; Cristina Vallongo; Fabio Vittadello; Fernanda Falcini; Annalisa Patrizi; Maria Alessio; Francesco La Torre; Rosa A Podda; Valeria Gerloni; Mario Cutrone; Anna Belloni-Fortina; Mauro Paradisi; Silvana Martino; Giorgio Perilongo
Journal:  Arthritis Rheum       Date:  2011-07

10.  A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings.

Authors:  Yvonne E Chiu; Sheetal Vora; Eun-Kyung M Kwon; Mohit Maheshwari
Journal:  Pediatr Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.588

View more
  4 in total

1.  Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties.

Authors:  Daniel H Glaser; Christina Schutt; Helena M VonVille; Kaila Schollaert-Fitch; Kathryn Torok
Journal:  Eur J Rheumatol       Date:  2020-02

Review 2.  Overview of Juvenile localized scleroderma and its management.

Authors:  Suzanne C Li; Rong-Jun Zheng
Journal:  World J Pediatr       Date:  2019-11-30       Impact factor: 2.764

3.  Parry Romberg syndrome presenting with a giant intracranial aneurysm: a case report.

Authors:  Ilse H de Lange; Anna Mt van Oploo; Feico Jj Halbertsma; F George Roos; Levinus A Bok
Journal:  Oxf Med Case Reports       Date:  2017-05-30

Review 4.  Immunopathogenesis of Pediatric Localized Scleroderma.

Authors:  Kathryn S Torok; Suzanne C Li; Heidi M Jacobe; Sarah F Taber; Anne M Stevens; Francesco Zulian; Theresa T Lu
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.